UroToday - European Urology

European Urology - Supraspinal Site of Action for the Inhibition of Ejaculatory Reflex by Dapoxetine
Thursday, 01 March 2007
Volume 51, Issue 3, Pages 825-832 (March 2007) Abstract - Objectives: The aim of the study was to determine whether dapoxetine, a short-acting selective serotonin reuptake inhibitor, acts at the spinal or supraspinal level to inhibit the ejaculatory reflex.
read more

European Urology - Presence of LDL Modified by Myeloperoxidase in the Penis in Patients with Vascular Erectile Dysfunction: A Preliminary Study
Monday, 01 January 2007
Volume 51, Issue 1, Pages 262-269 (January 2007) Abstract - Objective: Erectile dysfunction (ED) is a major vascular disorder. Atherosclerosis is closely related to lipoprotein metabolism and especially, oxidative modifications of low-density lipoproteins (LDLs), which are involved in early development of the atherosclerotic lesions.
read more

European Urology - The Premature Ejaculation Prevalence and Attitudes (PEPA) Survey: Prevalence, Comorbidities, and Professional Help-Seeking
Thursday, 01 March 2007
Volume 51, Issue 3, Pages 816-824 (March 2007) Abstract - Objectives: This study evaluated the associated comorbidities and patient satisfaction with treatment options for premature ejaculation (PE), a common sexual dysfunction.
read more

European Urology - Alterations in the Transforming Growth Factor (TGF)-β Pathway as a Potential Factor in the Pathogenesis of Peyronie's Disease
Monday, 01 January 2007
Volume 51, Issue 1, Pages 255-261 (January 2007) Abstract - Objectives: The development of fibrotic diseases is associated with alterations in the transforming growth factor β (TGF-β) pathway.
read more

European Urology - Therapeutic Effectiveness and Patient Satisfaction after 6 Months of Treatment with Tadalafil, Sildenafil, and Vardenafil: Results from the Erectile Dysfunction Observational Study (EDOS)
Thursday, 01 February 2007
Volume 51, Issue 2, Pages 541-550 (February 2007) Abstract - Objective: This observational study was conducted across Europe to assess health outcomes in men with erectile dysfunction (ED) who took tadalafil, sildenafil citrate (sildenafil), or vardenafil HCl (vardenafil) for 6 mo.
read more

European Urology - Seeking Answers on the Quest for Effective Nonsurgical Treatment of Peyronie's Disease
Tuesday, 13 February 2007
Volume 51, Issue 3, Pages 601-603 (March 2007) The quest for an effective nonsurgical treatment for Peyronie's disease is ongoing. Since the time of de la Peyronie, who prescribed the use of Barage spa water in 1743, hundreds of nonsurgical approaches have been proposed worldwide and still we are without a reliable cure.
read more

European Urology - Rebuttal from Authors re: Laurence A. Levine. Seeking Answers on the Quest for Effective Nonsurgical Treatment of Peyronie's Disease. Eur Urol 2007;51:601–3
Tuesday, 13 February 2007
Volume 51, Issue 3, Pages 603-604 (March 2007) I very much appreciate the opportunity to read and reply to Dr Levine's commentary concerning the evidence supporting plaque injection therapy in the treatment of Peyronie's disease.
read more

European Urology - Phosphodiesterase Type 5 Inhibitors: The Day After
Monday, 01 January 2007
Volume 51, Issue 1, Pages 75-89 (January 2007) Abstract - Objective: Review the literature on phosphodiesterase type 5 inhibitors (PDE5-Is), addressing critical issues in their current and future use, assessing unanswered questions, and identifying research needs.
read more

European Urology - Systematic Evidence-Based Analysis of Plaque Injection Therapy for Peyronie's Disease
Thursday, 15 February 2007
Volume 51, Issue 3, Pages 640-647 (March 2007) 1. Introduction Peyronie's disease, an acquired disease of the tunica albuginea surrounding the corpora cavernosa of the penis, affects approximately 3% of the male population with an average age at onset of 57 yr [1], [2], [3].
read more

browse categories

Member's Section

Quick Search

UroToday International Journal